REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Av Laboratories Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Lessors of Real Estate | Real Estate Property Managers | Administrative Management and General Management Consulting Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Advertising Agencies | Marketing Research and Public Opinion Polling | All Other Professional, Scientific, and Technical Services
Full name: Av Laboratories Sp. z o.o. Profile Updated: June 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Av Laboratories Sp. z o.o. is a company in Poland, with a head office in Wroclaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on July 19, 2019. Its’ total assets recorded a growth of 2.27%.

Headquarters
Ul. Lakiernicza 21/1
Wroclaw; Dolnoslaskie; Postal Code: 53-205

Contact Details: Purchase the Av Laboratories Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Av Laboratories Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Av Laboratories Sp. z o.o. report to view the information.
Incorporation Date:
July 19, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
85%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after Av Laboratories Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
2.27%▲
Total equity
-3.76%▼
Return on Equity (ROE)
N/A

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Celon S.A.
 
Mabion S.A.
Selvita Services Sp. z o.o.
 
Sartorius Stedim Poland Sp. z o.o.
Allbiotech Sp. z o.o.
 
Ansatbio Dynamics Sp. z o.o.
Lymelab Pharma Sp. z o.o.
 
Bbh Biotech Polska Sp. z o.o.
"Glg Pharma S.A."
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo